Atlas Trials

CMV Modulation of the Immune System in ANCA-associated Vasculitis

Clinical trial NCT01633476 · UNKNOWN

Trial details

NCT number
NCT01633476
Sponsor
Professor Lorraine Harper
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
ANCA Associated VasculitisCMV Infection
Start date
2013-07-01
Primary completion
2016-02-01
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.